Summary
- Closed for EoI
- Profile Type
- Business request
- POD Reference
- BRGB20240619004
- Term of Validity
- 19 June 2024 - 19 June 2025
- Company's Country
- United Kingdom
- Type of partnership
- Outsourcing agreement
- Targeted Countries
- Hungary
- Czechia
- France
- Finland
- Denmark
- Belgium
- Croatia
- Cyprus
- Bulgaria
- Ireland
- Estonia
- Austria
- Germany
- Greece
- Slovakia
- Romania
- Malta
- Lithuania
- Italy
- Poland
- Netherlands
- Spain
- Portugal
- Luxembourg
- Slovenia
- Latvia
- Sweden
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- A UK based SME have developed a product aimed at addressing a critical issue in postoperative cardiac tamponade. Their solution utilises cutting-edge technology to enable early diagnosis and intervention, reducing mortality rates and improving patient outcomes. The SME is seeking Original Equipment Manufacturers (OEMs) with expertise in the manufacture of medical grade cardiac equipment through an outsourcing agreement.
- Full Description
-
A UK based SME with a focus on cardiac innovation have developed a product aimed at addressing a critical issue in postoperative cardiac tamponade. The SME was established in 2014 and currently have a minimum viable product in place, which is at technology readiness level 4.
The product is designed to meet the unmet need for tamponade diagnosis while offering the added benefit of measuring cardiac output at no extra cost.
Ultimately, if post-cardiac surgery tamponade is suspected, it can only be excluded by opening the patient’s chest. If the diagnosis of cardiac tamponade is missed, it can lead to cardiac arrest which is resistant to Cardiopulmonary resuscitation (CPR) and requires immediate opening of the patient’s chest in the uncontrolled environment of the intensive care unit (ICU). This leads to high mortality (30-70%), poor outcomes for patients and high costs due to multi-organ support and renal dialysis. Early diagnosis of tamponade allows a planned return to theatre with reduced complications, mortality, and cost. Accurate diagnosis also stops unnecessary operations in patients with suspected tamponade benefiting both patients and the hospital.
The SME are progressing towards clinical trials and are actively seeking Original Equipment Manufacturers (OEMs) with expertise in the manufacture of medical grade equipment through an outsourcing agreement, to support with the development of the product. The expected outcome of the partnership is to accelerate the development of the SMEs flagship product from technology readiness level 4 to technology readiness level 7. - Advantages and Innovations
-
Company is dedicated to addressing a critical issue affecting 1.5 million cardiac surgery patients worldwide annually. With tamponade costing 4,500 lives and healthcare expenses reaching USD 2.4 billion each year, their focus lies in providing innovative solutions. Current solution is post-operative invasive surgery with no real diagnosis available.
The solution is a system that is placed at the end of heart surgery and diagnosis tamponade. It can simply be pulled through the surgery hole when finished with and disposed of.
Competitor products are expensive and do not diagnose the condition. - Stage of Development
- Under development
- Sustainable Development Goals
- Goal 3: Good Health and Well-being
- IPR description
-
• Original Equipment Manufacturers (OEMs) with expertise in medical grade cardiac equipment.
• Experience with producing therapeutics unlicensed specials.
• Good Manufacturing Practice (GMP) certification.
Partner Sought
- Expected Role of a Partner
- Original Equipment Manufacturers (OEMs) with expertise in medical grade cardiac equipment to accelerate the development of the device from technology readiness level 4 to technology readiness level 7. The partner will also be expected to support with the testing of the device including pilot studies.
- Type and Size of Partner
- SME 11-49
- SME <=10
- SME 50 - 249
- R&D Institution
- Type of partnership
- Outsourcing agreement
Dissemination
- Market keywords
- 05004005 - Diagnostic equipment
- Targeted countries
- Hungary
- Czechia
- France
- Finland
- Denmark
- Belgium
- Croatia
- Cyprus
- Bulgaria
- Ireland
- Estonia
- Austria
- Germany
- Greece
- Slovakia
- Romania
- Malta
- Lithuania
- Italy
- Poland
- Netherlands
- Spain
- Portugal
- Luxembourg
- Slovenia
- Latvia
- Sweden